Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 174,070,859 |
|
|||||
| News | - | ||||||
| Day High | 0.1525 | Low High |
|||||
| Day Low | 0.11 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ENDRA Life Sciences Inc | NDRA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0406 | 39.19% | 0.1442 | 04:54:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1256 | 0.11 | 0.1525 | 0.1036 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 135,463 | 174,070,859 | US$ 0.1269014 | US$ 22,089,836 | - | 0.0692 - 2.77 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 04:54:24 | 90 | US$ 0.1442 | USD |
ENDRA Life Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.1M | 8.45M | - | 0 | -10.06M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ENDRA Life Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 15/6/2024 | 06:01 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 14/6/2024 | 22:00 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 13/6/2024 | 07:22 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 06/6/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05/6/2024 | 14:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 04/6/2024 | 23:21 | Business Wire | ENDRA Life Sciences Announces Pricing of $8.0 Million Public.. |
| 01/6/2024 | 06:21 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 20/5/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/5/2024 | 22:00 | Business Wire | ENDRA Provides Update Following In-person Meeting with FDA |
| 15/5/2024 | 06:26 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 15/5/2024 | 06:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15/5/2024 | 06:05 | Business Wire | ENDRA Life Sciences Reports First Quarter 2024 Financial.. |
Historical NDRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1129 | 0.1525 | 0.0961 | 0.1072367 | 25,570,709 | 0.0313 | 27.72% |
| 1 Month | 0.334 | 0.334 | 0.0692 | 0.1263177 | 39,890,872 | -0.1898 | -56.83% |
| 3 Months | 0.93 | 1.00 | 0.0692 | 0.1291539 | 13,197,565 | -0.7858 | -84.49% |
| 6 Months | 1.48 | 2.77 | 0.0692 | 0.1438413 | 6,248,621 | -1.34 | -90.26% |
| 1 Year | 1.55 | 2.77 | 0.0692 | 0.1586137 | 3,155,015 | -1.41 | -90.70% |
| 3 Years | 42.40 | 47.00 | 0.0692 | 2.71 | 1,425,945 | -42.26 | -99.66% |
| 5 Years | 32.40 | 62.00 | 0.0692 | 11.05 | 1,113,890 | -32.26 | -99.55% |
